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Background: The aim of this retrospective study was to compare the morphological features of neurovascular ca-
nals and foramina of patients with medication-related osteonecrosis of the jaws (MRONJ) and healthy individuals 
by using cone beam computed tomography (CBCT).
Material and Methods: The CBCT images of 58 patients under bisphosphonate therapy diagnosed with MRONJ 
and age gender- matched controls were retrospectively evaluated. The diameter of mandibular and nasopalatine 
canal and mandibular, mental and lingual foramina were measured on several sections of CBCT. The value of 
mental index (MI) and panoramic mandibular index (PMI) were also assessed.
Results: The mean value of diametric measurements for all neurovascular canals and foramina in MRONJ patients 
were narrower than controls. Left mandibular foramen was the most affected area (p<0.001). There were signifi-
cantly difference in all measurements of mental foramen, lingual foramen and mandibular incisive canal between 
two groups (p<0.05). PMI of MRONJ subjects were also significantly differences in both sides (p<0.05).
Conclusions: In MRONJ patient, neurovascular canals and foramina are affected due to the alterations in bone 
remodeling. Therefore, the diametric measurement of neurovascular canals and assessment of MI and PMI on 
CBCT, is a potentially useful method for detection of early changes associated with bisphosphonate therapy and 
for predict areas where new necrosis may occur.




Medication-related osteonecrosis of the jaw (MRONJ) 
is a quite serious drug reaction, consisting of bone de-
struction in the maxillofacial region of patients. Osteo-
necrosis can be caused by two pharmacological agents: 
Antiangiogenic and antiresorptive drugs including 
bisphosphonates (BPs) receptor activator of nuclear 
factor kappa-B ligand inhibitors (1). Our study group 
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was consisted of BPs medicated patients. BPs are the 
first-choice antiresorptive drugs of management for 
diseases as osteoporosis, multiple myeloma, metastatic 
bone cancer, hypercalcemia related to malignancy and 
Paget’s (1). They are inorganic pyrophosphates effec-
tive in inhibiting osteoclast-mediated bone resorption 
(2). MRONJ is a severe complication of BP medica-
tion. Etiopathogenic mechanisms of MRONJ have been 
poorly understood. It generally occurs after a secondary 
infection or minor local trauma during a dental treat-
ment, but no work can clarify all morphological changes 
observed at the microscopic and macroscopic level (3).
The formation of BPs medication related osteonecro-
sis is related to long-term treatment with high levels 
of BPs and was first described in 2003 (4). According 
to the American Association of Oral and Maxillofacial 
Surgeons (5). MRONJ is described by the presence of 
exposed bone in the maxillofacial area more than 8 
weeks, an anamnesis of present or prior treatment with 
BPs and the exception of a radiation therapy history 
to the maxillofacial region. It may remain asymptom-
atic for months, hence Stage 0 was defined as a level 
of potentially emerging MRONJ in line with the clini-
cal guideline (5). It is associated with a high morbid-
ity, causing tooth mobility, pain, paraesthesia, halitosis, 
bone sequestrum formation and extraoral or intraoral 
fistula (6).
MRONJ is diagnosed based on clinical features but im-
aging is crucial for detecting early stages of disease. 
Although, various radiological techniques have been 
applied in MRONJ cases, conventional radiography and 
CT scans are commonly used. In recent years, cone-
beam CT (CBCT) has been presented as a diagnostic 
device using cone-beam geometry, flat panel detectors 
and 3D reconstruction algorithms that has lower doses 
and costs less than conventional CT (7).
The CBCT images are not only used as a tool for the 
measurement of morphological differences, but also are 
utilized for providing beneficial data to analyze even 
minor osseous differences. Therefore, CBCT can inves-
tigate sclerotic changes in the spongious bone of the jaw, 
non-healing extraction sockets and a thickened lamina 
dura as characteristic findings under medication with 
BP in individuals regarded as risk for MRONJ, even 
without the presence of a sequestrum or other clinical 
symptoms (6).
This study was aimed to investigate the changing in 
dimension of neurovascular canals, mental index (MI) 
and panoramic mandibular ındex (PMI) by using CBCT 
that may help to understand whether it is a diagnostic 
value in early diagnosis of MRONJ.
Material and Methods
- Study Group
The study group consisted by fifty-eight patients (26 fe-
males, 32 males, mean age 70.3 years; age range 49–84 
years) under bisphosphonate therapy were retrospec-
tively included between April 2012 and December 2016. 
Inclusion criteria were overt MRONJ diagnosed by a 
maxillofacial surgeon with 7 years of professional ex-
perience based on generally accepted diagnostic criteria 
of the clinical introduction (5). Patient with MRONJ in 
stage 1 and 2 (Stage 1: necrotic bone exposure in as-
ymptomatic patients with no evidence of soft-tissue 
infection; Stage 2: necrotic bone exposure associated 
with soft-tissue infection and pain) were included in 
study group (6). Patients with osteonecrosis that affect 
neurovascular structures in both sides were excluded. 
In study group all patients had MRONJ in one side of 
mandibular molar and angulus region.
CBCT images of patients with MRONJ had been ar-
chived in Department of Oral and Maxillofacial Radio-
logy, Faculty of Dentistry, Erciyes University. Control 
group was selected gender- and age-matched healthy 
individuals who had CBCT images performed for the 
treatment planning of implant-based prosthesis from 
the same archives (26 females, 32 males, mean age 70.2 
years; age range 51–82 years). The measurements were 
made on the same side as the patient group.
Owing to the retrospective nature of this study, ethi-
cal board approval was not required by local laws and 
regulations, and the informed consent requirement was 
waived by the departments where the study was carried 
out. The study was performed according to the guide-
lines of the Declaration of Helsinki concerning Ethical 
Principles for Medical Research Involving Human sub-
jects.
- Imaging Procedures
All study subjects underwent imaging using the New 
Tom VG (Quantitative Radiology, Verona, Italy) with 
flat-panel detector-based cone-beam computed tomog-
raphy (FPD-CBCT). The X-ray parameters (kV, mA) 
were automatically determined from scout views by the 
NewTom VG. All images were obtained with the patient 
in the supine position. Scanning time was 18 seconds, 
collimation height was 13 cm, exposure time was 3.6 
seconds, and voxel size was 0.3 mm3. Digital Imag-
ing and Communications in Medicine (DICOM) files 
obtained from the CBCT scans were reconstructed us-
ing NNT viewer software. Acquired 3D data were per-
formed by two independent readers who were blinded 
to each other and patient data (two radiologist with 4 
and 2 years of experience in head-and-neck imaging).
- Measurements
Jaw was divided to 5 sections and all measured sections 
were shown in Figure 1, on panoramic view. On CBCT 
scans obtained from MRONJ patients and healthy con-
trols the measurements were performed as follows: 
diameter of mental foramen (MenF) on axial and sag-
ittal slices (Fig. 2 a,b), on cross-sectional views; three 
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Fig. 1. The reconstructed panoramic images showed as follow, 1; mental foramina, 2-4; the measured 
sections through the mandibular canals, 5; mandibular foramina.
cross-section images with 1 cm intervals of mandibular 
canal (ManC) and mandibular foramen (ManF) were 
measured, bilaterally (Fig. 2c-f). The diametric mea-
surements for ManF and ManC were done at both mini-
mum and maximum diameter on cross- section images. 
For MI, mandibular cortical thickness was measured on 
the line, which was perpendicular to the bottom of the 
mandible at the middle of the mental foramen. The PMI 
was the ratio of the thickness of the mandibular cortex to 
the distance between the mental foramen and the infe-
rior mandibular cortex (Fig. 3a). On sagittal section, the 
diametric evaluation of nasopalatine canal (NPC) was 
assessed on nasopalatine foramen (NPF), incisive fora-
men (IF) and center of NPC (Fig. 3b).  In addition, the 
origin of mandibular incisive canal (MIC) was evaluated 
on sagittal images (Fig. 4a). The measurement of lingual 
foramen (LF) were performed on sagittal and axial sec-
tions (Fig. 4 b,c).- Statistical analyses.
Two oral radiologist were carried out all the measure-
ments independently and inter-observer reliability 
showed a high correlation. The measurements of the 
first observer with 4 years of experience were used for 
further analysis. Statistical analyses were conducted 
with SPSS for Windows SPSS® v. 16.0 (IBM Corp., 
Fig. 2. The demonstration of measurements on CBCT images. a. section 1+; cross-sectional measurements of mental 
foramen, b. section 1*; axial measurements of mental foramen. c-e. The minimum and maximum diametric measure-
ments through mandibular canal on section 2-4. f. The minimum and maximum diametric measurements of mandibular 
foramen on section 5.
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New York, NY; formerly SPSS Inc., Chicago, IL). The 
measurments were evaluated using the independent and 
paired samples t-test to compare the means of the all 
values between MRONJ and healthy sites and controls. 
Values of P<0.05 were considered to indicate statistical 
significance. 
Results
58 patients with MRONJ, osteonecrosis were found 
in 24 right and 34 left sides of the mandible (Table 1). 
However, the 24 right and 34 left sides of the 58 healthy 
individuals with no systemic disorder or medication 
were comprised in control group. 
All comparisons were performed reciprocally between 
both sides of patients with MRONJ and age-gender 
matched healthy individuals, expect non-measurable 
sites due to osteonecrosis. The evaluation was indicat-
ed narrowing in neurovascular canals of patients with 
MRONJ, relatively (Table 2). All the minimum diameter 
comparisons of the measurements of MenF in both sides 
were showed significantly differences between MRONJ 
subjects and controls (p<0.05). ManF and ManC were 
found statistically significant differences in both sides 
(p<0.05), expect first part of left ManC (p=0.45). The 
most contraction was observed in minimum diameter of 
left ManF (p<0.0001). Among the maximum diametric 
measurements, the significantly difference was found 
only at first part of right ManF (p=0.02). 
NPC comparisons showed that there were statistically sig-
nificant differences in diameters of NPF and center area 
(p=0.01, p=0.04, respectively). Although the mean value 
of IF diameter in MRONJ subjects were narrower than 
controls, there were no significantly difference between 
two groups (p=0.22). There were significantly differences 
in sagittal (p=0.01) and axial (p=0.02) diameters of LF and 
origin diameters of MIC on both sides (p<0.05).
There were significantly differences in both sides of 
PMI between patients with MRONJ and control group 
(p<0.05). But while, MI evaluation in left side was 
found significantly difference between two groups 
(p<0.0001), there were no significantly differences for 
the right sides of subjects (p=0.08). 
In patient group with MRONJ, because of osteonecro-
Fig. 3. a. x; mental index, x/y; panoramic mandibular index, b. The measurements of nasopalatine 
canal line 1;nasopalatine foramen, line 2; centre of canal, line 3; incisive foramen.
Fig. 4.  a. The measurements of origin of mandibular incisive canal. b Axial measurements of lingual foramen. c. Sagittal 
measurements of lingual foramen. 






 Localization of BRONJ in mandible
Gender Right side (12) Left side (17) Total
Number of 
Patients
Female 16 10 26
Male 8 24 32
Table 1. The distribution of patients with medication-related osteonecrosis of the 
jaw (MRONJ) according to gender.
Table 2. The mean value of neurovascular structures’ diameter, MI and PMI and also p value of comparisons 
between MRONJ subjects and controls. D; diameter, sag; sagittal, ax; axial, min; minumum, max; maximum.
*correlation is significant
 location MRONJ Control p value
Mental Foramen right axD 2.70±0.74 3.63±0.87 0,001*
corD 2.39±0.82 2.97±1.05 0,04*
left axD 2,91±0,86 3,79±1,01 0,005*
corD 2,42±0,84 3,03±0,87 0,02*
Mandibular Foramen right minD 2,62±0,54 3,01±0,61 0,01*
maxD 3,51±0,86 3,8±0,98 0,24
left minD 2,45±0,51 3,04±0,57 <0,0001*
maxD 3,59±0,69 3,97±0,87 0,07
Mandibular Canal right minD-1 1,76±0,62 2,3±0,43 0,01*
maxD-1 2,36±0,78 2,85±0,58 0,02*
minD-2 1,98±0,48 2,38±0,39 0,04*
maxD-2 2,59±0,75 2,78±0,53 0,31
 minD-3 2,03±0,60 2,64±0,55 0,01*
 maxD-3 2,86±0,88 3,09±0,62 0,22
left minD-1 2,04±0,59 2,16±0,52 0,45
maxD-1 2,52±0,87 2,68±0,55 0,48
minD-2 1,92±0,51 2,32±0,59 0,02*
maxD-2 2,47±0,73 2,8±0,66 0,11
minD-3 2,17±0,62 2,56±0,44 0,02*
maxD-3 2,91±0,78 3,03±0,57 0,56
Nasopalatine Canal  NF 2.63±1.11 3,83±1.1 0,01*
 centre 1,36±0,64 2,07±0,9 0,04*
 IF 2,96±0,97 3,33±1,03 0,22
Lingual  sagD 0,57±0,34 1,35±1,12 0,01*
Foramen  axD 0,64±0,77 1,55±1,45 0,02*
Mandibular Incisive 
Canal
 right 0.95±0.46 1.27±0.32 0,01*
left 1,06±0,47 1,32±0,38 0,04*
PMI right 3,03±0,75 4,12±1,22 0,02*
left 3,09±0,65 3,72±0,86 0,01*
MI right 4,18±0,79 3,44±0,89 0,08
left 4,5±0,85 3,55±0,67 <0,0001*
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sis we couldn’t make measurements bilaterally except 
MIC, MenF, ManF, MI and PMI. There are no signifi-
cant differences for MIC, MenF and ManF, but signifi-
cantly differences were found for MI and PMI between 
the osteonecrosed and healthy sides of patients with 
MRONJ (p<0.05) (Table 3) The mean values of PMI 
and MI were higher in MRONJ side. No significantly 
differences were found for all measurements on right 
and left sides of control group.
Discussion
The action mechanism of BPs in bone metabolism is not 
clarified. Due to BPs’ specific affinity to bone, they af-
fect almost only on osseous tissue when applied at phys-
iological doses; thus they accumulate not only in newly 
formed bone but also in vicinity to the osteoclasts. BPs 
also decrease bone blood flow and significantly reduce 
circulating levels of vascular endothelial growth factor, 
which is essential in the angiogenesis process (8). Fur-
thermore, Miglioratti (9) and Marx (10) have proposed 
that owing to their antiangiogenic effects, BPs may be 
directly in charge of MRONJ. MRONJ typically devel-
ops after injuries of the mucosa or simple dentoalveolar 
surgery, or is associated with inadequately well-fitting 
prostheses. Some papers had also been reported sponta-
neous cases (11-13).
BPs have specific affinity to bone like maxillary and 
mandible bones (8). Especially the periodontal and al-
veolar bone surfaces have high BP uptake and accu-
mulation. They also have relatively high rates of bone 
remodeling so these regions are more affected. Max-
illofacial region is exposed to the external situation 
through periodontal ligaments and teeth, this may be 
a probable cause of MRONJ only in the jaw (10,14). 
BPs show strong anti-osteoclastic activity (8). This may 
cause uncontrolled bone accumulation in bone surfaces 
of nourovascular canals and foramens. 
Currently, it was supposed that BP uptake, which is in di-
rect relationship to the local proportion of bone turnover, 
would actually be (approximately 100 times) higher in al-
veolar bone than in other skeletal sites (15,16). On account 
of these reasons, finding an early indicator of osseous 
changes in jaw may enable to understand before develop-
ing MRONJ. MRONJ at Stage 0 are defined a great risk 
of developing severity stages (17,18). Thus, it is critical to 
diagnose the early silent (asymptomatic) stage of MRONJ. 
Radiological bone changes specifying possibility of 
MRONJ might help dentists with preventive approach and 
treatment planning for patients under BP therapy.
Many osseous radiographic features related to MRONJ 
in panoramic and intraoral radiographies, computed to-
mography, magnetic resonance imaging, and positron 
emission tomography have been designated (2,19-23). 
Recently, CBCT is considered the most suitable im-
aging modality for MRONJ, because of its sufficient 
3D data for osseous structure, lower radiation doses 
and attainable cost. In the literature, the radiological 
findings of MRONJ lesions in CBCT were described 
as follow, increase in sclerotic expressions, failure of 
post-surgical remodelling, erosion on the cortical bone 
and subperiosteal bone deposition which are the most 
common and most characteristic features of MRONJ 
(2,24). Nevertheless, these radiographic findings seem 
useful for predicting that there is a potential early stage 
of MRONJ, there is no study about alterations in neuro-
vascular structures of MRONJ patients’ jaw. This study 
was planned to achieve initial findings of MRONJ by 
diametric measurements of jaws’ neurovascular canals 
and foramina on CBCT. 
Guggenberger et al. proved the benefits of CBCT in di-
agnosis MRONJ by qualitative and quantitative image 
parameters (1). Torres et al. used CBCT for evaluation 
of fractal dimension and mandibular cortical bone to 
diagnose early features of MRONJ (7,25). They found 
significantly differences in both study parameters be-
tween patients with BP medication and controls. Phal 
et al. also reported the sclerotic change encroached on 
the mandibular canal in 3 subjects of 15 patients with 
MRONJ (20). Based on the results of these studies, we 
thought that subperiostal bone accumulation may cause 
the changing on dimension of neurovascular constitu-
tion. The results of current study are supported to our 
opinion that the narrowing in neurovascular structure 
of patients with MRONJ is substantially.
The MI and PMI were utilized for assessment of differ-











    p-value 0.7 0.09 0.2 <0,05* <0,05*
MRONJ 
side    
Table 3. The comparison of MRONJ side and healthy side of MRONJ patients.
*correlation is significant
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In this study, there were significantly difference in in-
dexes between groups (p<0.05, except MI of right side). 
Furthermore, the results showed the most affected area 
is MenF whose all measurements’ were significantly 
differences between two groups. The diameter of LF 
was also found substantially narrowed in patients with 
MRONJ. The NPC, NPF, MIC and minimum diameter 
of ManF and ManC, which were significantly narrower 
in MRONJ subjects, may have a diagnostic value when 
display only some of them in small field of view (FOV). 
As a result, the present study suggested that these dia-
metric measurements and indexes are also useful tools 
for MRONJ risk evaluaion in BPs-exposed patients.
Due to nature of the retrospective study, present study 
was limited to the cases of MRONJ that were archived 
at the Department of Oral and Maxillofacial Radiology 
at the University of Erciyes, the main limitation of this 
study was the fact that the bisphosphonates type, un-
derlying disease, dose and duration of bisphosphonate 
therapy were not known. The risk for MRONJ has been 
indicated to be dependent on time, dose and type of 
bisphosphonates. But our parameters which were per-
formed in this retrospective study, are not affected by 
these clinical informations.
Conclusions
As known that an external effect is responsible for forma-
tion of MRONJ almost everytime, so the preventive ap-
proach is crucial for dentists. However, owing to the differ-
ence in neurovascular canal and foramen sizes, PMI and 
MI, CBCT evaluation of patients under bisphosphonates 
theraphy before surgical procedures could be able to dem-
onstrate the osseos changes of the jaws that may change 
the treatment plan according to bone conditions. Changes 
in dimension of neurovascular canals may be an indicator 
for early diagnosis, but in order to say that we would have 
to follow subjects when they start are on bisphosphonates 
see if the changes are a predictor of or early indicator of 
MRONJ in those who develop the condition.
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